MD Anderson study shows FGL2 protein may be an effective target for glioblastoma

IMAGE: This is Shulin Li, Ph.D. view more  Credit: MD Anderson Cancer Center HOUSTON – Researchers at The University of Texas MD Anderson Cancer Center have discovered an immune regulator that appears to dictate glioblastoma (GBM) progression by shutting down immune surveillance, indicating a potential new area of therapeutic investigation. Findings from the preclinical study led…

Cancer patients can quit smoking through lengthened medication time, counseling support

CHICAGO — Quitting smoking can significantly improve the effectiveness of cancer treatment, according to the U.S. Surgeon General, yet almost half of cancer patients continue to smoke after they’ve been diagnosed. A new study from Northwestern Medicine and the Abramson Cancer Center at the University of Pennsylvania found cancer patients have better success quitting and are not…